This site uses JavaScript!
Please activate JavaScript in your Browser settings...

Private Practice Center

Physicians and their medical specializations

Office visits by appointment only. Please call for an appointment: +43-1 367 13 73
Office hours     Monday - Friday   3pm – 8pm, Tuesday & Wednesday   9am – 2pm
Appointments may also be scheduled outside of regular office hours.

CV/Professional experience


Since 2017Chief of General&Vascular Surgery Department, Evangelic Hospital, Vienna
2015Professor of Surgery
2005-2014Chief of Surgery Department St. Josef Hospital, Vienna
2000-2005Director of Minimal Invasive Surgery, Medical University, Vienna
1996-2000Staff Surgeon Medical Univ. Vienna
1993-1994Research grant at Dept. of Molecular&Cell Biology, Univ. of California, Berkeley
1988-1999Specialist training in General + Vascular Surgery
1982-1988Medical University Vienna

Clinical and Research Areas
  • Minimal Invasive Surgery
  • Colorectal Surgery
  • Hernia Surgery
  • Sympathetic Surgery
  • Endoscopy
Medical Societies
  • President of ISSS International Society of Sympathetic Surgeons
  • Chairman of Minimally Invasive Surgery at UEMS – European Board of Surgery
  • Austrian Surgical Society
  • AMIC - Austrian Minimal Invasive Surgery (Past-President)
  • AHC Austrian Hernia Society
  • ÖGCH Austrian Society of Vascular Surgery
  • ACO – Arbeitsgemeinschaft Chirurgische Onkologie
  • EAES European Association of Endoscopic Surgeons

Resume & Career


Marek P. Ehrlich, MD is a native of Vienna, Austria, and studied medicine at the University of Vienna. He completed his medical training as a resident in general surgery and cardiac surgery at the University Hospital in Vienna and also held a fellowship as a postdoctoral chief research fellow at the Mount Sinai Hospital in New York. Dr. Ehrlich is currently an Associate Professor of Cardiac Surgery and Director of the Aortic Program at the University of Vienna. Dr. Ehrlich’s research interests have included experimental studies concerning cerebral protection in an animal model. Moreover, Dr. Ehrlich has served as a faculty member in several international symposia, is a reviewer of the Journal of Thoracic and Cardiovascular Surgery, Circulation and the Annals of Thoracic Surgery.

Furthermore, he is the organizer of the “VISAR” symposium which takes place biannually in Vienna.

He was awarded with several research prizes in Europe and the United States and received several grants from the Austrian Ministry of Health as well as the National Institute of Health (NIH) in Bethesda,Maryland, USA.

Dr. Ehrlich is the author and coauthor of over 300 numerous articles, abstracts and book chapter published in leading scientific journals.

Dr. Ehrlich lives in Vienna together with his wife Sharon and his son Lukas.

Detailed CV:
Name:Marek P. Ehrlich M.D
Professor of Surgery
Date of birth:April 20, 1966
Place of birth:Vienna, Austria
Business Address:Univ. Hospital Vienna
Dept. Cardiothoracic Surgery
Währinger Gürtel 18-20
1090 Vienna, Austria

Education:
Elementary school:1972 - 1976, Vienna
Gymnasium:1976 - 1984, Vienna
University Vienna:1984 - 1993
Graduation:Dr. Med. Univ. July 1993

International Research:
06 – 09. 1989:Dept. Heart Surgery Stanford, California, USA, with Prof. Shumway, Prof. Miller and Prof. Starnes
06. – 09. 1990:Dept. Heart Surgery Stanford, California, USA, with Prof. Shumway, Prof. Miller
08 – 09. 1990:Dept. Heart Surgery Birmingham, Alabama, USA, with Prof. Pacifico and Prof. Kirklin
08. – 09. 1991:Dept. Heart Surgery Baylor University Houston, Texas, USA, with Prof. Coselli
07/1997 – 06/1999:Postdoctoral chief research fellow at the Mount Sinai Hospital in New York with Prof. Randall Griepp

Training:
01/01/1995 – 30/04/2002:"Neuroprotection in Aortic Surgery"

Position now
  1. Associate Professor of Cardiac Surgery, Univ. of Vienna
  2. 2011 – now Director of Aneurysm Program, Univ. of Vienna
Surgical Oeuvre
Over 1500 Cardiac Procedures covering the hole spectrum of cardiac and aortic pathologies.

Consultant
2003 – 2004For company Cardiooptics
2003 – 2004For Stent company Endomed
2006 – nowfor Vascutek and Jotec
2010 –Consultant surgeon for Saudi German Hospitals

Publications:
Over 100 publications in Journals , 200 abstracts, 4 articles in cardiac books.
Ladies and Gentlemen,
The treatment of arterial disease has changed over the last few years.
New platelet-inhibiting and lipid-lowering medications may help avoid surgerical intervention. Should drug therapy be insuffiecient, other options are traditional surgery and minimally invasive procedures.
These include balloon dilation and stent implants in the case of vascular constriction; femoral artery aneurysm repair using stent grafts; and laser therapy to repair vaicose veins.
Some crucial questions to consider are: Which procedure offers the best risk-benefit ratio for you? Is a surgical procedure necessary, or can it be avoided?
These are some of the questions we can discuss together in a quiet setting.

For additional information on my range of treatment, please visit my website at www.gefaesschirurg-wien.at


Curriculum Vitae and Career


Born on September 18, 1973, married, 2 children, Roman Catholic.

Secondary Education:
1991-1998 Studied medicine at Medical University of Vienna. Clinical practice in Canada and Switzerland. 1998 Completed doctorate to become Dr. med. univ.

Dissertation:
September 1997-December 1998 Dissertation „Pharmakologische Regulation des Ryanodin Rezeptors“ (Pharmacological regulation of the ryanodine receptor) at Institut für Pharmakologie, signal transduction research group, under Prof. Dr. Michael Freissmuth

Habilitation:
In the field of surgery, June 2010: Targeted Tumor Therapy via Growth Factor and G-protein Coupled Receptor Signaling Components: Ex- and In-vivo Studies

Professional experience:
1999-2003FWF research assistant at the Pharmacological Institut,
research group under Prof. Freissmuth, MUW
June 2003 - September 2008Specialist training for general surgery at Universitätsklinik für Allgemein, Gefäß- und Transplantationschirurgie, AKH Vienna.
Since October 2008Specialist in general surgery at Universitätsklinik für Allgemein, Gefäß- und Transplantationschirurgie, AKH Vienna
2008-2010Awarded Executive MBA Health Care Management by Vienna University of Economics and Business.
Since July 2011Additional specialist training in vascular surgery
Since 2011Attending physician at University Department of Surgery
2015Fullfilment of qualification criteria at Medical University of Vienna
Since Oktober 2016FEBVS Fellow of the European Board of Vascular Surgery

Hobbies:
Piano, running

Awards & scholarships:
  • Scholarship from Hans und Blanca Moser Stiftung 1999
  • Aventis Preis 1999
  • Förderungspreis der Stadt Wien for innovative cancer research 2003
  • Theodor-Billroth-Preis from the Österreichischen Gesellschaft für Chirurgie (Austrian Society for Surgery) 2006
Selected publications:
  1. Eilenberg W, Stojkovic S, Piechota-Polanczyk A, Kaun C, Rauscher S, Gröger M, Klinger M, Wojta J, Neumayer C, Huk I, Demyanets S. Neutrophil Gelatinase-Associated Lipocalin (NGAL) is Associated with Symptomatic Carotid Atherosclerosis and Drives Pro-inflammatory State In Vitro. Eur J Vasc Endovasc Surg. (2016) 51: 623-31.
  2. Piechota-Polanczyk A, Demyanets S, Mittlboeck M, Hofmann M, Domenig CM, Neumayer C, Wojta J, Klinger M, Nanobachvili J, Huk I. The Influence of Simvastatin on NGAL, Matrix Metalloproteinases and Their Tissue Inhibitors in Human Intraluminal Thrombus and Abdominal Aortic Aneurysm Tissue. Eur J Vasc Endovasc Surg. (2015) 49: 549-55.
  3. Piechota-Polanczyk A, Demyanets S, Nykonenko O, Huk I, Mittlboeck M, Domenig CM, Neumayer C, Wojta J, Nanobachvili J, Klinger M. Decreased tissue levels of cyclophilin A, a cyclosporine a target and phospho-ERK1/2 in simvastatin patients with abdominal aortic aneurysm. Eur J Vasc Endovasc Surg. (2013) 45: 682-8.
  4. Piechota-Polanczyk A, Goraca A, Demyanets S, Mittlboeck M, Domenig C, Neumayer C, Wojta J, Nanobachvili J, Huk I, Klinger M. Simvastatin decreases free radicals formation in the human abdominal aortic aneurysm wall via NF-κB. Eur J Vasc Endovasc Surg. (2012) 44 :133-
  5. Klinger M, Tamandl D, Eipeldauer S, Hacker S, Herberger B, Kaczirek K, Dorfmeister M, Gruenberger B, Gruenberger T. Bevacizumab improves pathological response of colorectal cancer liver metastases treated with XELOX/FOLFOX. Ann Surg Oncol. (2010) 17: 2059-65.
  6. Klinger M, Eipeldauer S, Hacker S, Herberger B, Tamandl D, Dorfmeister M, Koelblinger C, Gruenberger B, Gruenberger T. Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases. Eur J Surg Oncol. (2009) 35: 515-20
  7. Klinger M, Farhan H, Just H, Drobny H, Himmler G, Loibner H, Mudde GC, Freissmuth M, Sexl V. Antibodies directed against Lewis-Y antigen inhibit signaling of Lewis-Y modified ErbB receptors. Cancer Res. (2004) 64: 1087-93.
  8. Klinger M, Kuhn M, Just H, Stefan E, Palmer T, Freissmuth M, Nanoff C. Removal of the carboxy terminus of the A2A-adenosine receptor blunts constitutive activity: differential effect on cAMP accumulation and MAP kinase stimulation. Naunyn Schmiedebergs Arch Pharmacol. (2002) 366: 287-98.
  9. Klinger M, Kudlacek O, Seidel MG, Freissmuth M, Sexl V. MAP kinase stimulation by cAMP does not require RAP1 but SRC family kinases. J Biol Chem. (2002) 277: 32490-7.
  10. Klinger M, Bofill-Cardona E, Mayer B, Nanoff C, Freissmuth M, Hohenegger M. Suramin and the suramin analogue NF307 discriminate among calmodulin-binding sites. Biochem J. (2001) 355: 827-33.
  11. Klinger M, Freissmuth M, Nickel P, Stäbler-Schwarzbart M, Kassack M, Suko J, Hohenegger M. Suramin and suramin analogs activate skeletal muscle ryanodine receptor via a calmodulin binding site. Mol Pharmacol. (1999) 55: 462-72.
Reviews:
  1. Klinger M, Freissmuth M, Nanoff C. Adenosine receptors: G protein-mediated signalling and the role of accessory proteins. Cell Signal. (2002) 14: 99-108.
Book contributions & patents:
  1. M. Klinger, M. G. Seidel, C. Höller, M. Platzer and M. Freissmuth. Activation of MAP Kinase by the A2A-Adenosine Receptor. Molecular Mechanisms of Signal Transduction. J.L. Bos, ed. (NATO Science Series Press, Amsterdam, ISBN 1 58603 016 7)
  2. Preparation based on an antibody directed against a tumor-associated glycosylation such as lewis structures, Juni 2004 PCT/EP2003/0069 12
Univ. Prof. Dr. Fritz Leutmezer

Univ. Prof. Dr. Fritz Leutmezer

Specialist in Neurology, Acupuncture
Web: www.neuro-logisch.at

Office hours Thursday afternoons — by appointment

About me


A sound doctor-patient relationship on equal ground is essential to my understanding of medicine. This includes first and foremost that the patient, whether they are ill or suspected to be ill, is thoroughly counseled and is involved in all stages of diagnosis and therapy.

My job as a doctor is to conscientiously obtain all necessary findings, to interpret them correctly, and to communicate any possible consequences in a clear and comprehensible manner.

Weighing all known risks and needs, I will work with my patients to ultimately develop the best possible therapeutic approaches.

In my function as a Lung Specialist in the 1st Lung Department at Otto Wagner Hospital, my focus lies on right cardiac catheter diagnostics and infectious diseases. In addition, I have dealt intensively with interstitial and rare lung diseases (orphan diseases).

At my private medical practice I am able to provide my patients with the care they deserve, in a peaceful environment. I also offer additional diagnostics and treatment at the Vienna Private Clinic, should it be necessary.

I have many years of experience treating asthma, COPD and lung cancer.

Curriculum Vitae


Personal:
Born and raised in Vienna,
Married, four children

Professional Career:
  • Studied at University of Vienna
  • Rotation at LKH Wolfsberg
  • Training as Specialist for Trauma Surgery and Sports Traumatology at UKH Meidling
  • Emergency Physician training
  • Founding member and partner at "Stosswellenzentrum Wien" www.stosswellenzentrum-wien.at
  • Currently Senior Physician at UKH Meidling
Professional:
  • Over 20 years of professional experience at the largest emergency hospital in Austria
  • Thorough emergency trauma surgery training
  • Focus on shoulder
  • Shoulder team UKH Meidling - outpatient shoulder clinic
  • Many years of experience with shockwave therapy (ESWT)
Additionally:
  • Consulting Trauma Surgeon at Rudolfinerhaus
  • Team Physician of Austrian Rugby record champion "Rugby Union Danube Vienna"
  • Team Physician of the Austrian National Rugby Team